Artículo de revisión Aplicaciones clínicas del PET

par González E,Patricio, Massardo V,Teresa, Canessa G,José, Humeres A,Pamela, Jofré M,M Josefina
Publié 2002

Representación de la incidencia y de la mortalidad por cáncer en los medios de comunicación chilenos

par Carrasco-García,Miguel Angel, Neira-Mellado,Carola, Klett,BáRbara, Cárcamo-Ulloa,Luis
Publié 2021

Role of Cardiac Biomarkers in Cancer Patients

par Gennaro Carmine Semeraro, Carlo Maria Cipolla, Daniela Maria Cardinale
Publié 2021

The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma

par Ling‐Long Tang, Yu‐Pei Chen, Chuan‐Ben Chen, Ming‐Yuan Chen, Nian‐Yong Chen, Xiao‐Zhong Chen, Xiao‐Jing Du, Wen‐Feng Fang, Mei Feng, Jin Gao, Fei Han, Xia He, Chao‐Su Hu, De‐sheng Hu, Guang‐Yuan Hu, Hao Jiang, Wei Jiang, Feng Jin, Jin‐Yi Lang, Jin‐Gao Li, Shao‐Jun Lin, Xu Liu, Qiu‐Fang Liu, Lin Ma, Hai‐Qiang Mai, Ji‐Yong Qin, Liang‐Fang Shen, Ying Sun, Pei‐Guo Wang, Ren‐Sheng Wang, Ruo‐Zheng Wang, Xiao‐Shen Wang, Ying Wang, Hui Wu, Yun‐Fei Xia, Shao‐Wen Xiao, Kun‐Yu Yang, Jun‐Lin Yi, Xiao‐Dong Zhu, Jun Ma
Publié 2021

Experience of the department of surgical treatment of bone and soft tissue tumors during COVID-19 pandemic period

par Artem V. Bukharov, Vitalii A. Derzhavin, Anna V. Yadrina, Dmtrii A. Erin
Publié 2021

Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurr...

par Puhalla S, Wilks S, Brufsky AM, O'Shaughnessy J, Schwartzberg LS, Berrak E, Song J, Vahdat L
Publié 2016

Immune oncology (IO) and metastatic lung cancer [CBD]: Curability, bony metastasis and duration of therapy

par Hunter C Cochran, Yadav Pandey, Richard W. Nicholas, Eric J. Del Giacco, A. Mazin Safar
Publié 2021

Mass Cytometry in Hematologic Malignancies: Research Highlights and Potential Clinical Applications

par John M. Astle, Huiya Huang
Publié 2021

The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?

par Lux MP, Ciani O, Dunlop WCN, Ferris A, Friedlander M
Publié 2021

N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine—A Review

par Michal Kyr, Adam Svobodnik, Radka Stepanova, Renata Hejnova
Publié 2021

Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care

par Pablo Gargallo, Silvestre Oltra, Yania Yáñez, Antonio Juan-Ribelles, Inés Calabria, Vanessa Segura, Marián Lázaro, Julia Balaguer, Teresa Tormo, Sandra Dolz, José María Fernández, Carolina Fuentes, Bárbara Torres, Mara Andrés, María Tasso, Victoria Castel, Jaime Font de Mora, Adela Cañete
Publié 2021

Universal Germline Testing of Unselected Cancer Patients Detects Pathogenic Variants Missed by Standard Guidelines without Increasing Healthcare Costs

par Adrienne T. Perkins, Derrick Haslem, Jessica Goldsberry, Katherine Shortt, Laura Sittig, Sharanya Raghunath, Christopher Giauque, Shawnee Snow, Gail Fulde, Bryce Moulton, David Jones, Lincoln Nadauld
Publié 2021

Tumor treating fields: An emerging treatment modality for thoracic and abdominal cavity cancers

par Travis H. Jones, Jonathan W. Song, Laith Abushahin
Publié 2022

Cancer Treatment and Research Communications

Publié 2021

Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies

par Ylenia Capodanno, Barbara Altieri, Richard Elders, Annamaria Colao, Antongiulio Faggiano, Joerg Schrader
Publié 2022

Breast cancer chemotherapy vascular toxicity: a review of mediating mechanisms and exercise as a potential therapeutic

par Marie Mclaughlin, Geraint Florida-James, Mark Ross
Publié 2021

Cancer-Immunity Cycle and Therapeutic Interventions- Opportunities for Including Pet Dogs With Cancer

par Samantha K. Von Rueden, Timothy M. Fan, Timothy M. Fan
Publié 2021